1. Home
  2. NFJ vs ABCL Comparison

NFJ vs ABCL Comparison

Compare NFJ & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

NFJ

Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

HOLD

Current Price

$13.78

Market Cap

1.3B

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NFJ
ABCL
Founded
2005
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NFJ
ABCL
Price
$13.78
$3.11
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$7.75
AVG Volume (30 Days)
223.5K
4.6M
Earning Date
01-01-0001
02-24-2026
Dividend Yield
9.01%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$35,325,000.00
Revenue This Year
N/A
$25.45
Revenue Next Year
N/A
$10.07
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.17
52 Week Low
$10.45
$1.89
52 Week High
$12.86
$6.52

Technical Indicators

Market Signals
Indicator
NFJ
ABCL
Relative Strength Index (RSI) 69.63 38.98
Support Level $13.62 $2.93
Resistance Level $13.58 $3.28
Average True Range (ATR) 0.13 0.24
MACD 0.02 -0.07
Stochastic Oscillator 98.11 23.59

Price Performance

Historical Comparison
NFJ
ABCL

About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest

Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: